0973-7510 Journal of Pure and Applied Microbiology 2581-690X DR. M.N. Khan 10.22207/JPAM.13.1.61 Determination of Level of 25-Hydroxy Vitamin D3 in Patients with Multiple Sclerosis and Its Effect on Disease Activity Jamal Yawuz Muhammad Qais Fadhil Ahmed Muhammad Abdulrasool Mohammed Sarmad Clinical Pharmacy Department, College of Pharmacy, University of Baghdad, Iraq Iraqi Medical Board Neurology, Ministry of Health, Baghdad Teaching Hospital, Iraq. 28 03 2019 13 1 545 551 Copyright © 2019 The Author(s) 2019 This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. https://creativecommons.org/licenses/by/4.0/

The current study was focused on patients with Multiple sclerosis between the ages group of 20 – 60. The objective of this study is to decide the level of 25-hydroxyvitamin D3 status in patients with multiple sclerosis (MS) and its engagement, with disease activity. A total of 31 cases have participated from Baghdad Teaching Hospital in Baghdad, Iraq during the period between March and April 2018. The results shows that, only significant finding was that, supplements for Vitamin D significantly increased its mean level in patients with Multiple Sclerosis (P < 0.05).

 Keywords Multiple sclerosis Vitamin-D